Mammoth Biosciences Patents

Patent portfolio assigned to Mammoth Biosciences (verified via public assignee records). US CRISPR platform co (Jennifer Doudna). Competitors are established CRISPR therapy/diagnostics firms (Caribou, Intellia, Editas, Beam, Sherlock). Pharma 'customers'/partners are paying collaborators: Vertex ($41M upfront, BioPharma Dive), Bayer ($40M upfront, Bayer press release), GSK Consumer Healthcare (COVID test, BioSpace). has_patents true: holds US10,253,365 & US10,337,051 (SynBioBeta) and Justia lists Mammoth-assigned patents; exact Google Patents count not enumerable (page blocked).